Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baljit Kaur

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
Expert Opinion on Therapeutic Patents|July 20, 2023
A patent review of NLRP3 inhibitors to treat autoimmune diseasesYiming Xu, Savannah Biby, Baljit Kaur, et al.
World Journal of Gastrointestinal Surgery|June 6, 2022
Including video and novel parameter-height of penetration of external anal sphincter-in magnetic resonance imaging reporting of anal fistulaPankaj Garg, Baljit Kaur, Vipul D Yagnik, et al.
Clinical and Experimental Gastroenterology|October 22, 2021
A New Anatomical Pathway of Spread of Pus/Sepsis in Anal Fistulas Discovered on MRI and Its Clinical ImplicationsPankaj Garg, Baljit Kaur, Vipul D Yagnik, et al.
European Journal of Medicinal Chemistry|July 2, 2025
Lead optimization of a CHI3L1 inhibitor for Glioblastoma: Enhanced target engagement, pharmacokinetics, and efficacy in 3D spheroid modelsBaljit Kaur, Hossam Nada, Longfei Zhang, et al.
European Journal of Medicinal Chemistry|July 15, 2025
CHI3L1-targeted small molecules as glioblastoma therapies: Virtual screening-based discovery, biophysical validation, pharmacokinetic profiling, and evaluation in glioblastoma spheroidsHossam Nada, Longfei Zhang, Baljit Kaur, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
CHI3L1-Targeted Small Molecules as Glioblastoma Therapies: Virtual Screening-Based Discovery, Biophysical Validation, Pharmacokinetic Profiling, and Evaluation in Glioblastoma SpheroidsHossam Nada, Longfei Zhang, Baljit Kaur, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 2021
Rationally designed TNF-α inhibitors: Identification of promising cytotoxic agentsBaljit Kaur, Sahil Mishra, Ramandeep Kaur, et al.
Tzu Chi Medical Journal|November 11, 2021
Extreme horseshoe and circumanal anal fistulas-challenges in diagnosis and managementPankaj Garg, Baljit Kaur, Vipul D Yagnik, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Structure-Guided Discovery of CHI3L1 Inhibitors from Ultralarge Chemical Spaces for Glioblastoma TherapyBaljit Kaur, François Sindt, Longfei Zhang, et al.
ACS Omega|January 19, 2026
Structure-Guided Discovery of CHI3L1 Inhibitors from Ultralarge Chemical Spaces for Glioblastoma TherapyBaljit Kaur, François Sindt, Longfei Zhang, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Expert Opinion on Therapeutic Patents|July 20, 2023
A patent review of NLRP3 inhibitors to treat autoimmune diseasesYiming Xu, Savannah Biby, Baljit Kaur, et al.
World Journal of Gastrointestinal Surgery|June 6, 2022
Including video and novel parameter-height of penetration of external anal sphincter-in magnetic resonance imaging reporting of anal fistulaPankaj Garg, Baljit Kaur, Vipul D Yagnik, et al.
Clinical and Experimental Gastroenterology|October 22, 2021
A New Anatomical Pathway of Spread of Pus/Sepsis in Anal Fistulas Discovered on MRI and Its Clinical ImplicationsPankaj Garg, Baljit Kaur, Vipul D Yagnik, et al.
European Journal of Medicinal Chemistry|July 2, 2025
Lead optimization of a CHI3L1 inhibitor for Glioblastoma: Enhanced target engagement, pharmacokinetics, and efficacy in 3D spheroid modelsBaljit Kaur, Hossam Nada, Longfei Zhang, et al.
European Journal of Medicinal Chemistry|July 15, 2025
CHI3L1-targeted small molecules as glioblastoma therapies: Virtual screening-based discovery, biophysical validation, pharmacokinetic profiling, and evaluation in glioblastoma spheroidsHossam Nada, Longfei Zhang, Baljit Kaur, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
CHI3L1-Targeted Small Molecules as Glioblastoma Therapies: Virtual Screening-Based Discovery, Biophysical Validation, Pharmacokinetic Profiling, and Evaluation in Glioblastoma SpheroidsHossam Nada, Longfei Zhang, Baljit Kaur, et al.
Bioorganic & Medicinal Chemistry Letters|March 26, 2021
Rationally designed TNF-α inhibitors: Identification of promising cytotoxic agentsBaljit Kaur, Sahil Mishra, Ramandeep Kaur, et al.
Tzu Chi Medical Journal|November 11, 2021
Extreme horseshoe and circumanal anal fistulas-challenges in diagnosis and managementPankaj Garg, Baljit Kaur, Vipul D Yagnik, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Structure-Guided Discovery of CHI3L1 Inhibitors from Ultralarge Chemical Spaces for Glioblastoma TherapyBaljit Kaur, François Sindt, Longfei Zhang, et al.
ACS Omega|January 19, 2026
Structure-Guided Discovery of CHI3L1 Inhibitors from Ultralarge Chemical Spaces for Glioblastoma TherapyBaljit Kaur, François Sindt, Longfei Zhang, et al.
Pageof 9